RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
-7.93%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$973M
AUM Growth
+$973M
(-21%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-14.06%
Top 10 Holdings %
Top 10 Hldgs %
31.9%
Holding
97
New
2
Increased
29
Reduced
54
Closed
5
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$13.1M |
| 2 |
Cigna
CI
|
$10.1M |
| 3 |
Biogen
BIIB
|
$8.66M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$6.47M |
| 5 |
Humana
HUM
|
$6.15M |
Top Sells
| 1 |
Natera
NTRA
|
$17M |
| 2 |
Becton Dickinson
BDX
|
$14.7M |
| 3 |
Boston Scientific
BSX
|
$13M |
| 4 |
HCA Healthcare
HCA
|
$12.6M |
| 5 |
Glaukos
GKOS
|
$11.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Transmedics
TMDX
$3.65B
| $2.37M | 0.24% |
38,000
-7,270
| -16% | -$453K |
|
77
Privia Health
PRVA
$2.84B
| $2.37M | 0.24% |
121,189
+26,000
| +27% | +$508K |
|
78
Medpace
MEDP
$13.5B
| $2.26M | 0.23% |
6,800
-700
| -9% | -$233K |
|
79
Alkermes
ALKS
$4.95B
| $2.24M | 0.23% |
77,999
-55,001
| -41% | -$1.58M |
|
80
Bruker
BRKR
$4.45B
| $2.13M | 0.22% |
36,315
-8,000
| -18% | -$469K |
|
81
IDEAYA Biosciences
IDYA
$2.26B
| $2.11M | 0.22% |
82,000
-45,500
| -36% | -$1.17M |
|
82
Relay Therapeutics
RLAY
$709M
| $1.9M | 0.19% |
460,000
| – | – |
|
83
Immunocore
IMCR
$1.78B
| $1.72M | 0.18% |
58,278
| – | – |
|
84
Pliant Therapeutics
PLRX
$105M
| $1.53M | 0.16% |
116,250
-4,000
| -3% | -$52.7K |
|
85
Xenon Pharmaceuticals
XENE
$2.99B
| $1.37M | 0.14% |
35,000
| – | – |
|
86
Avantor
AVTR
$8.74B
| $1.3M | 0.13% |
61,826
+17,826
| +41% | +$376K |
|
87
Repligen
RGEN
$6.54B
| $1.3M | 0.13% |
9,000
-1,000
| -10% | -$144K |
|
88
INmune Bio
INMB
$52.4M
| $833K | 0.09% |
178,284
| – | – |
|
89
Amgen
AMGN
$153B
| $782K | 0.08% |
3,000
| – | – |
|
|
IGMS
90
DELISTED
IGM Biosciences
IGMS
| $770K | 0.08% |
126,064
-59,395
| -32% | -$363K |
|
91
Acadia Healthcare
ACHC
$2.15B
| $545K | 0.06% |
13,750
-92,000
| -87% | -$3.65M |
|
92
Bio-Techne
TECH
$8.3B
| $216K | 0.02% |
3,000
-17,000
| -85% | -$1.22M |
|
93
Madrigal Pharmaceuticals
MDGL
$9.7B
| – | – |
-15,300
| Closed | -$3.25M |
|
94
Evolent Health
EVH
$1.11B
| – | – |
-265,000
| Closed | -$7.49M |
|
95
ESSA Pharma
EPIX
$11.2M
| – | – |
-804,649
| Closed | -$4.88M |
|
96
DexCom
DXCM
$30.9B
| – | – |
-87,000
| Closed | -$5.83M |
|
97
BridgeBio Pharma
BBIO
$9.91B
| – | – |
-268,000
| Closed | -$6.82M |
|